Morepen Laboratories Ltd

Shares of Morepen Laboratories soared 6.46 per cent at Rs 61.89 per share on the BSE in Monday's intraday trade

Drug firm Morepen Laboratories on Thursday said its consolidated net profit declined by 55 per cent to Rs 12 crore for the fourth quarter ended March 2022.

Pharma major Morepen Laboratories has started the production of the test batch of the Russian Sputnik V coronavirus vaccine in Himachal Pradesh, the company has said

Morepen Laboratories board approved the issue of up to 5 crore equity shares to Liquid Holdings, an entity belonging to the promoter group of the company, at a price of Rs 38 per equity share

Morepen Laboratories said its board has approved raising over Rs 433 crore through issue of shares to Switzerland's private venture capital firm Corinth Investment Holdings and Liquid Holdings

Atorvastatin and Montelukast have shown great growth potential during last 5 years, with a CAGR of 25% and 17% respectively